Holdings
Baker Bros. Advisors LP
As of Sep 30, 2026, Baker Bros. Advisors LP reported 75 positions worth US$20.3B. Largest: Incyte Corporation, BeOne Medicines Ltd. Class A and Revolution Medicines, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Incyte Corporation | 30.8M | US$3.73B | +322 | Sep 30, 2026 |
| BeOne Medicines Ltd. Class A | 8.83M | US$3.23B | +30,768 | Sep 30, 2026 |
| Revolution Medicines, Inc. | 10.6M | US$2.18B | −806K | Sep 30, 2026 |
| Kodiak Sciences Inc | 21.9M | US$2.07B | +1.94M | Sep 30, 2026 |
| Madrigal Pharmaceuticals, Inc. | 2.14M | US$1.08B | no change | Sep 30, 2026 |
| Insmed Incorporated | 8.8M | US$1B | no change | Sep 30, 2026 |
| Kymera Therapeutics, Inc. | 8.66M | US$968M | no change | Sep 30, 2026 |
| ACADIA Pharmaceuticals Inc. | 42.9M | US$865M | no change | Sep 30, 2026 |
| GRAIL, Inc. | 4.03M | US$564M | no change | Sep 30, 2026 |
| Summit Therapeutics Inc. | 32.8M | US$554M | no change | Sep 30, 2026 |